Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nancy Sue Barta"'
Autor:
Susan Boroski, David Gray, Lynne Denny, Wenjian Xu, Brian M. Campbell, Nancy C. Stratman, Al Probert, Amy B. Dounay, Lori M. Evans, Nancy Sue Barta
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 19:6604-6607
Compounds that are both norepinephrine reuptake inhibitors (NRI) and 5-HT1(A) partial agonists may have the potential to treat neuropsychiatric disorders including attention deficit hyperactivity disorder (ADHD) and depression. Targeted screening of
Autor:
Brian Nichelson, Mark G. Vartanian, Charles Taylor, Susan M. Lotarski, Nancy Sue Barta, Sean D. Donevan, Sian E. Gibbons, Norman L. Colbry, Zhu Zhijian, Melvin R. Dickerson, Paul Galatsis, Russell J. DeOrazio, Jacob Bradley Schwarz, Kristin Knapp Lin, Zheng Li, Andrew John Thorpe, Jack J. Kinsora, Raymond Andrew Hudack, David J. Wustrow, David D. Manning, Ayman El-Kattan
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 16:3559-3563
Several beta-amino tetrazole analogs of gabapentin 1 and pregabalin 2 were prepared by one of two convergent, highly efficient routes, and their affinity for the alpha(2)-delta protein examined. Two select compounds with potent affinity for alpha(2)-
Autor:
Dong Liming, Xinjun Hou, Elizabeth A. Lunney, Corinne E. Augelli-Szafran, Deal Judith G, Christopher F. Bigge, Darin Vanderpool, Raymond Andrew Hudack, Nancy Sue Barta, Bradley William Caprathe, Chuangxing Guo, Steve Bender, Richard E. Showalter, Lorraine Kathleen Fay, Arindam Chatterjee
Publikováno v:
Journal of Medicinal Chemistry. 49:1202-1206
Since the discovery that FK-506 promotes neurite outgrowth, considerable attention has been focused on the development of potent nonimmunosuppressive ligands for FK-506 binding proteins (FKBPs). Such neuroimmunophilin agents have been reported to sho
Autor:
Nancy Sue Barta, Steven A. Weissman, Paul J. Reider, Kara B. Somerville, Daniel R. Sidler, Robert D. Larsen
Publikováno v:
Organic Letters. 2:2821-2824
[reaction: see text] Chiral oxazolidin-2-ones are synthetically valuable as chiral auxiliaries, and many have pharmaceutically interesting biological activity. This communication focuses on a convenient, practical one-pot preparation of chiral 4,5-di
Autor:
Alan E. Rowan, Jorge M. M. Verkade, Nancy Sue Barta, Sudip Malik, Brian Gibson, Floris L. van Delft, John Cooke Hodges, Anup M. Jawalekar
Publikováno v:
Molecules, 18, 7, pp. 7346-7363
Molecules
Molecules, 18, 7346-7363
Molecules, Vol 18, Iss 7, Pp 7346-7363 (2013)
Volume 18
Issue 7
Pages: 7346-7363
Molecules
Molecules, 18, 7346-7363
Molecules, Vol 18, Iss 7, Pp 7346-7363 (2013)
Volume 18
Issue 7
Pages: 7346-7363
Copper-free click chemistry between cyclooctynes and azide is a mild, fast and selective technology for conjugation of oligonucleotides. However, technology for site-specific introduction of the requisite probes by automated protocols is scarce, whil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::796d0d9c31bb7860cc9ebadcb7a14afd
https://hdl.handle.net/2066/117135
https://hdl.handle.net/2066/117135
Autor:
Joanne Brodfuehrer, Cheryl Li, Christopher Lepsy, Amy B. Dounay, Brian M. Campbell, Nancy Sue Barta, David Gray, Liming Zhang, Taraneh Haske
Publikováno v:
The AAPS journal. 14(2)
Evidence suggests that compounds possessing both norepinephrine reuptake inhibition and 5-HT1A partial agonism (NRI/5-HT1A) activities may have a greater efficacy in treating neuropsychiatric disorders than compounds possessing either activity alone.
Autor:
Elizabeth M. Collantes, Kim Zoski, David Gray, Tammy Whisman, Nancy Sue Barta, Samarendra N. Maiti, Rajendra Subedi, Daniel F. Ortwine, Rathna Iyer, Lynne Denny, Satavisha Dutta, Al Probert, Corey Coleman, Nancy C. Stratman, Amy B. Dounay, Wenjian Xu, Brian M. Campbell, Dongfeng Hou
Publikováno v:
Bioorganicmedicinal chemistry letters. 20(3)
Preclinical studies suggest that compounds with dual norepinephrine reuptake inhibitor (NRI) and 5-HT 1A partial agonist properties may provide an important new therapeutic approach to ADHD, depression, and anxiety. Reported herein is the discovery o
Publikováno v:
ChemInform. 40
Autor:
Brian M. Campbell, Amy B. Dounay, Pil H. Lee, Nancy Sue Barta, Lori M. Evans, Terry Crawford, Susan A. Borosky, Wenjian Xu, David Gray, Lynne Denny, Jack A. Bikker, Edward A. Lenoir
Publikováno v:
Bioorganicmedicinal chemistry letters. 19(4)
Aminopyrimidine 2 (4-(1-(2-(1H-indol-3-yl)ethyl)piperidin-3-yl)-N-cyclopropylpyrimidin-2-amine) emerged from a high throughput screen as a novel 5-HT(1A) agonist. This compound showed moderate potency for 5-HT(1A) in binding and functional assays, as
Publikováno v:
Bioorganicmedicinal chemistry letters. 18(20)
As part of a discovery effort aimed at identifying novel norepinephrine reuptake inhibitors (NRIs), a number of substituted morpholines were designed and synthesized. The target compounds contain vicinal stereogenic centers, and the program was great